CIK 0001699382 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Net income (USD) | -73.3 M | -57.8 M | -34.4 M | |
| Diluted EPS (USD/shares) | -1.48 | -1.61 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-05 | 4 | 4 | 2026-10-01 |
| 2026-10-05 | 3 | 3 | 2026-10-01 |
| 2026-10-05 | 8-K | 8-K items 5.02,7.01,9.01 | 2026-10-01 |
| 2026-09-15 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-09-02 | 8-K | 8-K items 1.01,8.01,9.01 | 2026-08-31 |
| 2026-09-02 | 424B5 | 424B5 | |
| 2026-08-31 | 424B3 | 424B3 | |
| 2026-08-31 | 424B5 | 424B5 | |
| 2026-08-31 | 8-K | 8-K items 8.01,9.01 | 2026-08-31 |
| 2026-08-14 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-14 | 8-K | 8-K items 2.02,9.01 | 2026-08-14 |
| 2026-07-28 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-10 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-06-05 | 4 | 4 | 2026-06-04 |
| 2026-06-05 | 4 | 4 | 2026-06-04 |
| 2026-06-05 | 4 | 4 | 2026-06-04 |
| 2026-06-05 | 4 | 4 | 2026-06-04 |
| 2026-06-05 | 4 | 4 | 2026-06-04 |
| 2026-06-05 | 8-K | 8-K items 5.07 | 2026-06-04 |
| 2026-05-15 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-05-12 | 10-Q | 10-Q | 2026-03-31 |
| 2026-05-12 | 8-K | 8-K items 2.02,9.01 | 2026-05-12 |
| 2026-05-04 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-04-22 | ARS | ARS | 2025-12-31 |
| 2026-04-22 | DEFA14A | DEFA14A |
Forms on file (last 1,000): 4 160, 8-K 46, SC 13G/A 33, 3 27, 10-Q 18, SC 13G 16, SCHEDULE 13G/A 12, S-8 7. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=PMVP (0.002 USD), /gw/filings/filings?ticker=PMVP&form=8-K, /gw/filings/facts?ticker=PMVP&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange